Office management of benign breast disease

Clinical Obstetrics and Gynecology

Volumn 42, Issue 2, 1999, Pages 234-248

  Zylstra, Samuel ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Milford Whitinsville Reg Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; BREAST ABSCESS; BREAST BIOPSY; BREAST CYST; BREAST DISCHARGE; BREAST DISEASE; BREAST DUCT ECTASIA; BREAST EXAMINATION; BREAST FIBROADENOMA; BREAST PAPILLOMA; CLINICAL FEATURE; FEMALE; GALACTORRHEA; HUMAN; MAMMOGRAPHY; MASTALGIA; MASTITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; SCINTIMAMMOGRAPHY;

AMBULATORY CARE; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; MAMMOGRAPHY; MASTITIS; NIPPLES;

EID: 0033385887     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199906000-00008     Document Type: Article

References (20)

1. Marchant DJ. The role of the gynecologist in the management of breast disease. Int J Gynecol Obstet. 1993;43:3-13.
2. Hindle WH. Breast Disease for Gynecologists. East Norwalk, CT: Appleton and Lange, 1990:xiii.
3. United States General Accounting Office. Breast cancer, 1971-91. Prevention, treatment, and research. GAO/PEMD-92-12: 12-18. Washington, DC: General Accounting Office, 1992.
4. Zylstra S, Bors-Koefoed R, Mondor M, Anti S, Giordano K, Ressequie L. A statistical model for predicting the outcome in breast cancer malpractice lawsuits. Obstet Gynecol. 1994;84:392-398.
5. Kern KA. Preventing the delayed diagnosis of breast cancer through medical litigation analysis. Surg Oncol Clin North Am. 1994; 3:101-123.
6. Love SM, Gelman RS, Silen W. Fibrocystic "disease" of the breast - A nondisease. N Engl J Med. 1982;307:1010-1014.
7. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): A new perspective of pathogenesis and nomenclature of benign breast disorders. Lancet. 1987;2:1316.
8. Patey DH, Nurck AW. Natural history of cystic disease of the breast treated conservatively. BMJ 1953;1:15-17.
9. Drukker BH. Fibrocystic change and fibrocystic disease of the breast. Obstet Gynecol Clin North Am. 1987;14:685-702.
10. Leis HP Jr. Concepts regarding breast biopsies. Breast Disease. 1991;4:223.
11. Holleb AI, Farrow JH. The significance of nipple discharge. CA Cancer J Clin. 1966;16:182.
12. Takeda T, Suzuki M, Sato Y, Hase T. Cytologie studies of nipple discharges. Acta Cytol. 1982;26:35-36.
13. Jonsson S, Pulkkinen MO. Mastitis today: Incidence, prevention, and treatment. Ann Chir Gynaecol. 1994;208(suppl):84-87.
14. Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A. Mondor's disease and breast cancer. Cancer. 1992;69:2267-2270.
15. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-151.
16. Page DL, Vanderzwagg R, Rogers LW, Williams LT, Walker WE, Martmann WH. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst. 1978;61:1055-1063.
17. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
18. Page DL, Dupont WD, Rogers LW. Breast cancer risk of lobular-based hyperplasia after biopsy: "Ductal" pattern lesions. Cancer Detection Prevention. 1986;9:441-448.
19. Kopans DB, D'Orsi CJ, Adler DD, et al. Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology, 1993.
20. American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS). 2nd edition. Reston, VA: American College of Radiology, 1995.